Scot A. Niglio

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

Andrea B. Apolo, Rosa Nadal, Daniel M. Girardi et al. · Journal of Clinical Oncology · 2020 · 134 citations · Full text

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

Andrea B. Apolo, Karla V. Ballman, Guru Sonpavde et al. · New England Journal of Medicine · 2024 · 125 citations · Full text

Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial

Andrea Necchi, M. Roumiguié, Ashish M. Kamat et al. · The Lancet Oncology · 2024 · 73 citations · Full text

Urology, Surgical Oncology, Oncology +6

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

Talal El Zarif, Amin H. Nassar, Gregory R. Pond et al. · JNCI Journal of the National Cancer Institute · 2023 · 49 citations · Full text

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

Heather J. Chalfin, Tiziano Pramparo, Amir Mortazavi et al. · Clinical Cancer Research · 2020 · 48 citations · Full text